What is ESLA's dilution risk score?

ESLA has a latest available DilutionScore record of 84/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for ESLA, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for ESLA?

DilutionWatch tracks 25 SEC filing types for ESLA including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect ESLA shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For ESLA, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for ESLA tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for ESLA. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

ESLA Dilution Risk Score: 84/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

95

📊 Float Risk

57

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 44%

💰 Capital Raise model 55%

• Critical: only 0.1 months cash remaining

🔄 Reverse Split model est. 45%

• 50-day avg $1.37 approaching $1 threshold

• Only 0 months cash — financial pressure

📉 Score Deterioration model 15%

• Score already CRITICAL (84/100) — events likely imminent

🔔 Track ESLA — Get forecast alerts →

Market Data

Market Cap$46.91M

Shares Outstanding43.50M

Float14.11M

Cash$100.0K

DebtN/A

Short InterestN/A

Institutional Holdings

12.2% institutional ownership

Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers

🔔 Track ESLA for full holder detail →

Short Interest

Short Interest48.1K

Days to Cover1.0

% of Float0.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2023-06-30

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual ESLA Dilution Snapshot

Estrella Immunopharma, Inc. (ESLA) has a DilutionScore of 84/100, rated Critical dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for ESLA: xbrl on 2026-06-30; xbrl on 2023-06-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.